Shares of Intel (INTC 6.30%) are flying higher on Tuesday. The company's stock gained 6.6% as of 3 p.m.
Google grows search market share as AI platforms gain users — Positive
GOOG GOOGL Proactive Investors — February 11, 2025Google grew its share of the global search market by 5 basis points in January as it faces potential competition from new AI entrants, new data from Statcounter has shown. However, Alphabet Inc (NASDAQ:GOOG)-owned Google has seen its share of global search fall by 169 basis points year-over-year, while Bing has gained 51 basis points over the same period.
C3.ai: Riding AI Coattails
Waymo Expands in LA: Everything to Know About the Growing Robotaxi Service — Positive
GOOG GOOGL CNET — February 11, 2025Here's everywhere you can hail a ride, and where else Waymo will soon arrive.
Blackstone Inc. (BX) Bank of America Securities Financial Services Conference 2025 Transcript — Neutral
BX Seeking Alpha — February 11, 2025Blackstone Inc. (NYSE:BX ) Bank of America Securities Financial Services Conference 2025 February 11, 2025 10:30 AM ET Company Participants Michael Chae - Vice Chairman and Chief Financial Officer Conference Call Participants Craig Siegenthaler - Bank of America Craig Siegenthaler Good morning, everyone. And welcome to Bank of America's 33rd Annual Financial Services Conference.
Ford Chief Executive Says Trump Policies May Lead to Layoffs — Negative
F NYTimes — February 11, 2025The executive, Jim Farley, said President Trump's tariff and auto policies would raise costs and could force the automaker to cut jobs.
FTAI Aviation Ltd. (FTAI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
FTAI PRNewsWire — February 11, 2025LOS ANGELES , Feb. 11, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to FTAI Aviation Ltd.
Integral Ad Science Holding Corp. (IAS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
IAS PRNewsWire — February 11, 2025BENSALEM, Pa. , Feb. 11, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Transocean Ltd. (RIG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
RIG PRNewsWire — February 11, 2025LOS ANGELES , Feb. 11, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Transocean Ltd. ("Transocean" or the "Company") (NYSE: RIG ).
Logility Announces Date of Third Quarter Fiscal Year 2025 Financial Results — Neutral
LGTY Business Wire — February 11, 2025ATLANTA--(BUSINESS WIRE)--Logility Supply Chain Solutions, Inc. (Logility) (NASDAQ: LGTY), a leader in AI-first supply chain planning software, today announced that it will release its third quarter fiscal year 2025 financial results after the U.S. financial markets close on Thursday, February 20, 2025. Due to the transaction pending with Aptean, Logility will not be hosting an earnings conference call to review the results and will not be providing a financial outlook. About Logility Logility.
Fluence Energy, Inc. (FLNC) Q1 2025 Earnings Call Transcript — Neutral
FLNC Seeking Alpha — February 11, 2025Fluence Energy, Inc. (NASDAQ:FLNC ) Q1 2025 Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Lexington May - Vice President Finance and Investor Relations Julian Nebreda - President and Chief Executive Officer Ahmed Pasha - Chief Financial Officer Conference Call Participants George Gianarikas - Canaccord Genuity Brian Lee - Goldman Sachs Dylan Nassano - Wolfe Research Andrew Percoco - Morgan Stanley Mark Strouse - J.P. Morgan Chris Dendrinos - RBC Capital Markets Kashy Harrison - Piper Sandler Jordan Levy - Truist Securities Vikram Bagri - Citi Julien Dumoulin-Smith - Jefferies Operator Good day, and thank you for …
Anduril to take over Microsoft's U.S. Army $22-billion headset program — Positive
MSFT CNBC — February 11, 2025Anduril Industries, Palmer Luckey's defense-tech startup, will take over Microsoft's multibillion-dollar augmented reality headset program with the U.S. Army, the companies announced Tuesday. The partnership will give the drone software maker "oversight of production, future development of hardware and software, and delivery timelines" if approved by the Department of Defense.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX — Neutral
PCRX PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Nextracker Inc. of Class Action Lawsuit and Upcoming Deadlines - NXT — Neutral
NXT PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Crocs, Inc. of Class Action Lawsuit and Upcoming Deadlines - CROX — Neutral
CROX PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or the "Company") (NASDAQ: CROX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Joint Stock Company Kaspi.kz of Class Action Lawsuit and Upcoming Deadlines - KSPI — Neutral
KSPI PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ: KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT — Neutral
APLT PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN — Neutral
REGN PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capri Holdings Limited of Class Action Lawsuit and Upcoming Deadlines - CPRI — Neutral
CPRI PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited ("Capri" or the "Company") (NYSE: CPRI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN — Neutral
AZN PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.